UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant ☒ |
|
Filed by a Party other than the Registrant ☐ |
|
Check the appropriate box: |
|
|
|
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) |
☒ |
Definitive Proxy Statement |
☐ |
Definitive Additional Materials |
☐ |
Soliciting Material Pursuant to Rule 14a‑12 |
Veeco Instruments Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box): |
|
|
|
☒ |
No fee required. |
☐ |
Fee computed on table below per Exchange Act Rules 14a‑6(i)(1) and 0‑11. |
|
|
|
(1) Title of each class of securities to which transaction applies:___________ |
|
|
|
(2) Aggregate number of securities to which transaction applies:___________ |
|
|
|
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
|
|
|
(4) Proposed maximum aggregate value of transaction:_____________ |
|
|
|
(5) Total fee paid:____________ |
|
|
☐ |
Fee paid previously with preliminary materials. |
☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
(1) Amount Previously Paid:_____________ |
|
(2) Form, Schedule or Registration Statement No.:____________ |
|
(3) Filing Party:_____________ |
|
(4) Date Filed:______________ |
|
1 Terminal Drive Plainview, New York 11803 U.S.A. Phone (516) 677‑0200 Fax (516) 677‑0380 www.veeco.com |
March 19, 2019
2019 Annual Meeting of Stockholders
Dear Fellow Stockholder:
It is my pleasure to invite you to join me at the 2019 Annual Meeting of Stockholders of Veeco Instruments Inc. to be held on Friday, May 3, 2019, at 8:30 a.m. Eastern Time, at 333 South Service Road, Plainview, New York 11803.
At this year’s meeting, we will vote on:
(1) The election of three directors named in the attached proxy statement to hold office until the 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
(2) An amendment and restatement of Veeco’s 2010 Stock Incentive Plan;
(3) An amendment to Veeco’s 2016 Employee Stock Purchase Plan to increase the authorized shares of Veeco’s common stock thereunder by 750,000 shares; and
(4) The ratification of KPMG LLP as Veeco’s independent registered public accounting firm.
We will also conduct a non-binding advisory vote to approve the compensation of the Company’s named executive officers.
We use the U.S. Securities and Exchange Commission rule that allows companies to furnish proxy materials to their stockholders over the internet. We believe this expedites stockholder’s receipt of proxy materials, lowers annual meeting costs and conserves natural resources. Thus, we are mailing to many stockholders a Notice of Internet Availability of Proxy Materials (“Notice”), rather than copies of the Proxy Statement and our 2018 Annual Report to Stockholders on Form 10‑K. The Notice contains instructions on how to access the proxy materials online, vote online and obtain your copy of our proxy materials.
Your vote is very important. I encourage you to sign and return your proxy card, or use telephone or internet voting prior to the meeting, so that your shares will be represented and voted at the meeting.
Sincerely,
William J. Miller, Ph.D.
Chief Executive Officer
VEECO INSTRUMENTS INC.
NOTICE OF 2019 ANNUAL MEETING OF STOCKHOLDERS
DATE AND TIME: |
|
Friday, May 3, 2019, 8:30 a.m., Eastern Time |
|
|
|
PLACE: |
|
333 South Service Road, Plainview, New York 11803 |
|
|
|
ITEMS OF BUSINESS: |
|
1. To elect three directors named in the attached proxy to hold office until the 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified; 2. To approve an amendment and restatement of Veeco’s 2010 Stock Incentive Plan; 3. To approve an amendment to Veeco’s 2016 Employee Stock Purchase Plan to increase the authorized shares of Veeco’s common stock thereunder by 750,000 shares; 4. To hold a non-binding advisory vote on 2018 named executive officer compensation; 5. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2019; and 6. To consider such other business as may properly come before the meeting. |
|
|
|
WHO CAN VOTE: |
|
You must be a stockholder of record at the close of business on March 11, 2019 to vote at the Annual Meeting. |
|
|
|
INTERNET AVAILABILITY: |
|
We are using the internet as our primary means of furnishing proxy materials to most of our stockholders. Rather than sending those stockholders a paper copy of our proxy materials, we are sending them a notice with instructions for accessing the materials and voting via the internet. This Proxy Statement and our 2018 Annual Report on Form 10‑K are available free of charge at www.veeco.com. |
|
|
|
PROXY VOTING: |
|
We cordially invite you to participate in the Annual Meeting, either by attending and voting in person or by voting through other acceptable means. Your participation is important, regardless of the number of shares you own. You may vote by telephone, through the internet or by mailing your completed proxy card. |
|
By order of the Board of Directors, |
|
|
|
Gregory A. Robbins |
|
Senior Vice President, General Counsel and Secretary |
|
|
|
March 19, 2019 |
|
Plainview, New York |
1 | |
|
|
4 | |
Security Ownership of Certain Beneficial Owners and Management |
4 |
5 | |
|
|
6 | |
6 | |
6 | |
6 | |
7 | |
8 | |
8 | |
8 | |
9 | |
9 | |
10 | |
Certain Contractual Arrangements with Directors and Executive Officers |
10 |
|
|
11 | |
11 | |
12 | |
27 | |
28 | |
30 | |
30 | |
33 | |
34 | |
35 | |
40 | |
|
|
42 | |
42 | |
43 | |
43 | |
44 | |
|
|
45 | |
45 | |
46 | |
Proposal 2 – Amendment and Restatement of the 2010 Stock Incentive Plan |
49 |
Proposal 3 – Amendment to the 2016 Employee Stock Purchase Plan |
57 |
61 | |
62 | |
|
|
63 | |
|
|
|
|
A-1 |
|
B-1 |
To assist you in reviewing the proposals to be acted upon at the Veeco Instruments Inc. (“Veeco” or the “Company”) 2019 Annual Meeting of Stockholders (the “Annual Meeting”), we call your attention to the following information about the proposals and voting recommendations, the Company’s director nominees, and highlights of the Company’s corporate governance and executive compensation. The following description is only a summary. For more complete information about these topics, please review the complete proxy statement.
Proposals and Voting Recommendations
Voting Matters |
Board Vote |
Proposal 1: Election of three nominees named herein as directors |
FOR each nominee |
Proposal 2: Approval of the 2010 Stock Incentive Plan, as Amended and Restated |
FOR |
Proposal 3: Approval of an Amendment to the 2016 Employee Stock Purchase Plan |
FOR |
Proposal 4: Advisory vote to approve the compensation of our Named Executive Officers, or “Say on Pay” |
FOR |
Proposal 5: Ratification of the appointment of our independent registered public accounting firm for 2019 |
FOR |
Summary of Information Regarding the Board of Directors
Members of Veeco’s Board of Directors (“Board of Directors” or the “Board”) are listed below. Messrs. Peeler and St. Dennis have been nominated for re-election to the Board. Dr. Miller is also nominated for election to the Board, in connection with his promotion as the Company’s Chief Executive Officer (“CEO”) effective October 1, 2018.
|
|
Director |
|
Committee Membership |
||
Name |
Age |
since |
Independent (1) |
AC |
CC |
GC |
Kathleen A. Bayless |
62 |
2016 |
Yes |
M/FE |
|
|
Richard A. D’Amore |
65 |
1990 |
Yes (Lead Independent Director) |
|
M |
|
Gordon Hunter |
67 |
2010 |
Yes |
|
C |
M |
Keith D. Jackson |
63 |
2012 |
Yes |
M/FE |
|
C |
William J. Miller, Ph.D. |
50 |
2018 |
No |
|
|
|
John R. Peeler |
64 |
2007 |
No |
|
|
|
Peter J. Simone |
71 |
2004 |
Yes |
C/FE |
|
M |
Thomas St. Dennis |
65 |
2016 |
Yes |
|
M |
|
(1) |
Independence determined based on NASDAQ rules. |
AC – Audit Committee CC – Compensation Committee GC – Governance Committee
|
C – Chairperson M – Member FE – Audit committee financial expert (as determined based on SEC rules) |
1
Corporate Governance Highlights
Board and Other Governance Information |
As of March 19, 2019 |
Size of Board as Nominated |
8 |
Average Age of Director Nominees and Continuing Directors |
63 |
Average Tenure of Director Nominees and Continuing Directors |
9.9 years |
Percentage of Continuing Directors and Nominees who are Independent |
75% |
Percentage of Directors who attended all Board Meetings |
100% |
Number of Director Nominees and Continuing Directors Who Serve on More Than Three Public Company Boards |
0 |
Directors Subject to Stock Ownership Guidelines (3 times annual cash retainers) |
Yes |
Annual Election of Directors |
No |
Voting Standard |
Majority |
Plurality Voting Carve-out for Contested Elections |
Yes |
Independent Chairman |
No |
Lead Independent Director |
Yes |
Independent Directors Meet Without Management Present |
Yes |
Annual Board, Committee and Individual Director Self-Evaluations, Including Use of External Governance Advisor at Least Every 3 Years |
Yes |
Annual Independent Director Evaluation of CEO |
Yes |
Risk Oversight by Full Board and Committees |
Yes |
Board Orientation/Education Program |
Yes |
Code of Conduct Applicable to Directors |
Yes |
Stockholder Ability to Call Special Meetings |
50% of Outstanding Shares |
Stockholder Ability to Act by Written Consent |
No |
Poison Pill |
No |
Executive Compensation Highlights
Here’s What We Do…
Pay for Performance. We ensure that the compensation of the CEO and the other named executive officers listed in the Summary Compensation Table below (collectively, the “NEOs”) tracks the Company’s performance. Our compensation programs reflect our belief that the ratio of performance-based compensation to fixed compensation should increase with the level of the executive, with the greatest amount of performance-based compensation at the CEO level.
Peer Group Selection. As addressed in the Compensation Discussion and Analysis section below, we made changes to our Peer Group for 2019 with an increased focus, for example, on companies operating in the semiconductor equipment and adjacent industry segments, and those that were included in the Institutional Shareholder Services, Inc. (“ISS”) defined peer group. Changes included the addition of ten new companies, seven of which are smaller than Veeco in terms of annual revenue.
Performance-based Long-Term Incentives. The majority of the long-term incentive compensation provided to our CEO and other NEOs prior to October 2018 was awarded in the form of performance-based restricted stock units that feature a minimum three-year target performance period, were capped at 150% of target, and are subject to 100% forfeiture. Beginning in October 2018, we adopted performance measures based on total shareholder return over a three-year period, comparing the Company’s performance to the Russell 2000 Index. Awards were capped at 200% of target and are subject to 100% forfeiture.
Minimum Vesting. Our 2010 Stock Incentive Plan specifies a one year minimum vesting period for all equity awards, except for up to 5% of the maximum number of shares available or in the event of certain
2
circumstances (e.g., death, disability, corporate transactions). Time-based awards granted to executives feature vesting periods ranging from three to four years.
Stock Option Provisions. Our 2010 Stock Incentive Plan prohibits the cash buyout of underwater stock options and the repricing of stock options without stockholder approval; the Company has not engaged in either of these practices.
Double-Trigger Change in Control Arrangements. Our Senior Executive Change in Control Policy features a narrow change in control definition, requiring an actual change in control and termination of employment before change in control benefits are triggered. The situations where an executive is eligible to resign with “good reason” are limited to: (i) reductions in base salary, (ii) relocation by more than 50 miles, (iii) significant reductions in total benefits, for our CEO and our Chief Financial Officer/Chief Operating Officer (“CFO/COO”) only, and (iv) for our CEO only, a diminution in position. These provisions are not triggered by bankruptcy. See “Potential Payments Upon Termination or Change in Control” below for more information.
Clawback Policy. Our Compensation Recoupment Policy provides that in the event of a financial restatement due to fraud or intentional illegal conduct as determined by the independent members of the Board of Directors, a culpable executive officer may be required to reimburse the Company for performance-based cash compensation if the amount of such compensation would have been lower had it been calculated based on such restated financial statements. Beginning in 2019, compensation subject to recoupment was expanded to include equity compensation.
Stock Ownership Guidelines. Our stock ownership guidelines require our NEOs and our Board of Directors to hold Veeco stock in a specified multiple of their base salaries or annual cash retainers, subject to a phase-in period. For example, Veeco’s CEO is required to hold Veeco stock with a value equal to at least six times his base salary (this amount was increased by the Company in March 2019 from four times his base salary). Pursuant to these guidelines, covered individuals are required to hold at least 50% of the net after-tax shares realized upon vesting or exercise until the ownership guidelines are met.
Hedging and Pledging Restrictions. Our insider trading policy prohibits all employees and directors from hedging or pledging their Veeco shares.
Annual Bonus. Amounts that can be earned under our annual incentive programs are based solely on performance against corporate financial and individual goals. Awards under the programs are not guaranteed and are capped at 200% of target.
Annual Say-on-Pay Vote. We conduct an annual Say-on-Pay advisory vote.
Stockholder Engagement. We routinely engage with stockholders and, as appropriate, with proxy advisory firms, to better understand their perspective regarding executive compensation best practices and have incorporated many of these practices in our executive compensation programs.
Here’s What We Don’t Do…
No Multi-Year Guarantees. We do not offer multi-year guarantees for salary increases, bonuses or equity awards.
No Overly Generous Change in Control Benefits. We have used change in control protections sparingly and have limited cash payments to 1.5 to 2.0 times base salary and bonus.
No Gross-Ups. We do not provide tax gross ups for benefits that may become payable in connection with a change in control.
Limited Pension Benefits. We do not maintain a defined benefit pension plan or a supplemental executive retirement plan. The Company’s 401(k) savings plan is its only pension benefit.
No Retirement Benefits. We do not offer retirement health and welfare benefits to our employees.
No Excessive Perquisites. We do not provide executives with perquisites such as financial planning, corporate aircraft, etc.
3
Security Ownership of Certain Beneficial Owners and Management
The following table sets forth certain information regarding the beneficial ownership of Veeco common stock as of March 11, 2019 (unless otherwise specified below) by (i) each person known by Veeco to own beneficially more than five percent of the outstanding shares of Veeco common stock, (ii) each director of Veeco, (iii) each NEO, and (iv) all executive officers and directors of Veeco as a group. Unless otherwise indicated, Veeco believes that each of the persons or entities named in the table exercises sole voting and investment power over the shares of Veeco common stock that each of them beneficially owns, subject to community property laws where applicable.
|
Shares of Common Stock |
Percentage of |
||
|
Beneficially Owned (1) |
Total Shares |
||
|
|
|
|
Outstanding |
|
Shares |
Options |
Total |
(1) |
|
|
|
|
|
5% or Greater Stockholders: |
|
|
|
|
BlackRock, Inc. (2) |
6,899,071 |
— |
6,899,071 |
14.4% |
The Vanguard Group (3) |
4,538,789 |
— |
4,538,789 |
9.4% |
Oppenheimer Funds, Inc. (4) |
4,039,700 |
— |
4,039,700 |
8.4% |
Dimensional Fund Advisors LP (5) |
3,070,380 |
— |
3,070,380 |
6.4% |
River and Mercantile Asset Management LLC (6) |
2,948,949 |
— |
2,948,949 |
6.1% |
|
|
|
|
|
Directors: |
|
|
|
|
Kathleen A. Bayless |
18,228 |
— |
18,228 |
* |
Richard A. D'Amore |
102,933 |
— |
102,933 |
* |
Gordon Hunter |
36,592 |
— |
36,592 |
* |
Keith D. Jackson |
32,792 |
— |
32,792 |
* |
William J. Miller, Ph.D. (7) |
160,550 |
117,310 |
277,860 |
* |
John R. Peeler (7) |
384,722 |
282,610 |
667,332 |
1.4% |
Peter J. Simone |
31,975 |
— |
31,975 |
* |
Thomas St. Dennis |
18,240 |
— |
18,240 |
* |
|
|
|
|
|
Named Executive Officers: |
|
|
|
|
William J. Miller, Ph.D. (7) |
160,550 |
117,310 |
277,860 |
* |
John R. Peeler (7) |
384,722 |
282,610 |
667,332 |
1.4% |
Shubham Maheshwari (7) |
117,404 |
54,000 |
171,404 |
* |
John Kiernan |
33,474 |
49,854 |
83,328 |
* |
All Directors and Executive Officers as a Group (10 persons) |
936,910 |
503,774 |
1,440,684 |
3.0% |
*Less than 1%.
(1) |
A person is deemed to be the beneficial owner of securities owned or which can be acquired by such person within 60 days of the measurement date upon the exercise of stock options. Shares owned include unvested restricted stock awards (but do not include unvested restricted stock units). Each person’s percentage ownership is determined by assuming that stock options beneficially owned by such person (but not those owned by any other person) have been exercised. |
(2) |
Share ownership information is based on information contained in a Schedule 13G/A filed with the SEC on January 31, 2019. The address of this holder is 55 East 52nd Street, New York, New York 10055. |
4
(3) |
Share ownership information is based on information contained in a Schedule 13G/A filed with the SEC on February 11, 2019. The address of this holder is 100 Vanguard Boulevard, Malvern, Pennsylvania 19355. |
(4) |
Share ownership information is based on information contained in a Schedule 13G filed with the SEC on January 14, 2019. The address of this holder is 225 Liberty Street, New York, New York 10281. |
(5) |
Share ownership information is based on information contained in a Schedule 13G/A filed with the SEC on February 8, 2019. The address of this holder is Building One, 6300 Bee Cave Road, Austin, Texas 78746. |
(6) |
Share ownership information is based on information contained in a Schedule 13G filed with the SEC on February 15, 2019. The address of this holder is 30 Coleman Street, London, EC2R 5AL, United Kingdom. |
(7) |
Share ownership for these individuals includes purchases of Company stock made by these individuals, on their own account, in 2018 and in prior years. In 2018, Dr. Miller and Messrs. Peeler and Maheshwari purchased Company stock in the amounts of 10,000 shares, 10,000 shares, and 13,900 shares, respectively. |
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) requires Veeco’s officers and directors, and persons who own more than 10% of Veeco’s common stock, to file reports of ownership and changes in ownership with the Securities and Exchange Commission (“SEC”). These persons are required by SEC regulations to furnish Veeco with copies of all Section 16(a) forms they file. SEC regulations require us to identify in this proxy statement anyone who filed a required report late or failed to file a required report. Based on our review of forms we received, or written representations from reporting persons, we believe that during 2018 all Section 16(a) filing requirements were satisfied on a timely basis.
5
Veeco’s Board of Directors and management are committed to responsible corporate governance to ensure that Veeco is managed for the long-term benefit of its stockholders. To that end, the Board of Directors and management review published guidelines and recommendations of institutional stockholder organizations and current best practices of similarly situated public companies. The Board and management periodically evaluate and, when appropriate, revise Veeco’s corporate governance policies and practices in light of these guidelines and other findings, and to comply with the requirements of the Sarbanes-Oxley Act of 2002 and the rules and listing standards issued by the SEC and by The NASDAQ Stock Market LLC (“NASDAQ”).
Veeco’s Corporate Governance Guidelines provide that at least two-thirds of the Board of Directors must be independent in accordance with the NASDAQ listing standards. In fact, 75% of Veeco’s eight continuing directors and nominees are independent, and none serve on more than two other public company boards. All of Veeco’s directors attended each Board meeting, and each applicable committee meeting, held in 2018. Veeco undergoes an annual Board, committee and individual director self-evaluation process, and the independent directors, guided by the independent Lead Director, meet regularly without management and perform an annual performance assessment of our CEO.
Governance Policies and Practices
Veeco has instituted a variety of policies and practices to foster and maintain corporate governance, including the following:
Corporate Governance Guidelines - Veeco adheres to written Corporate Governance Guidelines, adopted by the Board and reviewed by the Governance Committee from time to time. The Corporate Governance Guidelines govern director qualifications, conflicts of interest, succession planning, periodic board self-assessment and other governance matters. The Board has used an outside governance advisor to facilitate the board self-assessment at least every three years.
Code of Business Conduct - Veeco maintains written standards of business conduct applicable to all of its employees worldwide.
Code of Ethics for Senior Officers - Veeco maintains a Code of Ethics that applies to our CEO, CFO/COO and Chief Accounting Officer.
Environmental, Health & Safety Policy - Veeco maintains a written policy that applies to all of its employees with regard to environmental, health and safety matters.
Director Education Policy - Veeco has adopted a written policy under which it encourages directors to attend, and provides reimbursement for the cost of attending, director education programs. A majority of Veeco’s Board members has attended one or more director education programs within the past five years.
Disclosure Policy - Veeco maintains a written policy that applies to all of its employees with regard to the dissemination of information.
Board Committee Charters - Each of Veeco’s Audit, Compensation and Governance Committees has a written charter adopted by Veeco’s Board that establishes practices and procedures for each committee in accordance with applicable corporate governance rules and regulations.
Copies of each of these documents can be found on the Company’s website (www.veeco.com) via the “Investors” page.
Veeco’s Corporate Governance Guidelines provide that at least two-thirds of the Board of Directors must be independent in accordance with the NASDAQ listing standards. In addition, service on other boards must be
6
consistent with Veeco’s conflict of interest policy and the nature and time involved in such service is reviewed when evaluating suitability of individual directors for election.
Independence of Current Directors. Veeco’s Board of Directors has determined that all of the directors are “independent” within the meaning of the applicable NASDAQ listing standards, except Dr. Miller, the Company’s CEO, and Mr. Peeler, the Executive Chairman of the Board.
Independence of Committee Members. All members of Veeco’s Audit, Compensation and Governance Committees are required to be and are independent in accordance with NASDAQ listing standards.
Compensation Committee Interlocks and Insider Participation. During 2018, none of Veeco’s executive officers served on the board of directors of any entity whose executive officers served on Veeco’s Compensation Committee. No current or past executive officer of Veeco serves on our Compensation Committee. The members of our Compensation Committee are Messrs. D’Amore, Hunter and St. Dennis.
Board Access to Independent Advisors. The Board members have full and free access to the officers and employees of Veeco and are permitted to retain independent legal, financial or other advisors as the Board or a Committee deems necessary.
Director Resignation Upon Change in Employment. The Corporate Governance Guidelines provide that a director shall submit his resignation if he changes his principal employment from what it was when he was elected as a director, or undergoes a change affecting his qualification as a director or fails to receive the required number of votes for re-election. Upon such submission, the Board shall determine whether to accept or reject the resignation. If the resignation is tendered for failure to receive the required number of votes for re-election, the Governance Committee will also inform the Board of any other action it recommends be taken.
Mr. Peeler, the Company’s former CEO, serves as Executive Chairman of the Board. We have a separate, independent Lead Director. Although we do not have a formal policy addressing the topic, we believe that when the Chairman of the Board is not independent, it is important to have a separate Lead Director, who is an independent director.
Mr. D’Amore serves as the Lead Director. In that role, he presides over the Board’s executive sessions, during which our independent directors meet without management, and he serves as the principle liaison between management and the independent directors of the Board. The Lead Director also:
· |
Confers with the Chairman of the Board regarding Board meeting agendas; |
· |
Has the authority to call meetings of the independent directors; |
· |
Chairs meetings of the independent directors including, where appropriate, setting the agenda and briefing the Chairman of the Board on issues discussed during the meeting; |
· |
Oversees the annual performance evaluation of the CEO; |
· |
Consults with the Governance Committee and the Chairman of the Board regarding assignment of Board members to various committees; and |
· |
Performs such other functions as the Board may require. |
Mr. D’Amore has served as Lead Director since 2016.
We believe the combination of Mr. Peeler as our Executive Chairman of the Board and an independent director as our Lead Director is an effective structure for the Company. The division of duties and the additional avenues of communication between the Board and our management associated with this structure provide the basis for the proper functioning of our Board and its oversight of management.
7
The Board has an active role, as a whole and also at the committee level, in overseeing management of the Company’s risks. The Board regularly reviews information regarding the Company’s strategy, finances and operations, as well as the risks associated with each. The Audit Committee is responsible for oversight of Company risks relating to accounting matters, financial reporting, internal controls and legal and regulatory compliance. The Audit Committee undertakes, at least annually, a review to evaluate these risks. Individual members of the Audit Committee are each assigned an area of risk to oversee. The members then meet separately with management responsible for such area, including the Company’s CFO/COO, Chief Accounting Officer, internal auditor and general counsel, and report to the Audit Committee on any matters identified during such discussions with management. In addition, the Governance Committee manages risks associated with the independence of the Board and potential conflicts of interest. The Company’s Compensation Committee is responsible for overseeing the management of risks relating to the Company’s executive compensation plans and arrangements. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board is regularly informed about such risks through committee reports.
Our Compensation Committee conducted a risk-assessment of our compensation programs and practices and concluded that our compensation programs and practices, as a whole, are appropriately structured and do not pose a material risk to the Company. Our compensation programs are intended to reward the management team and other employees for strong performance over the long-term, with consideration of near-term actions and results that strengthen and grow our Company. We believe our compensation programs provide the appropriate balance between short-term and long-term incentives, focusing on sustainable operating success for the Company. We consider the potential risks in our business when designing and administering our compensation programs, and we believe our balanced approach to performance measurement and compensation decisions mitigates the likelihood that individuals will be encouraged to undertake excessive or inappropriate risk. Further, our compensation program administration is subject to considerable internal controls and when determining the principal outcomes – performance assessments and compensation decisions – we rely on principles of sound governance and good business judgment.
During 2018, Veeco’s Board held eight meetings. It is the policy of the Board to hold executive sessions without management at every regularly scheduled board meeting and as requested by a director. The Lead Director or Committee Chairperson, as appropriate, presides over these executive sessions. All members of the Board are welcome to attend the Annual Meeting of Stockholders. In 2018, Mr. Peeler was the only director who attended the Annual Meeting. The Board has established the following committees: an Audit Committee, a Compensation Committee, and a Governance Committee.
Audit Committee. As defined in Section 3(a)(58)(A) of the Exchange Act, the Company established an Audit Committee which reviews the scope and results of the audit and other services provided by Veeco’s independent registered public accounting firm. The Audit Committee consists of Ms. Bayless and Messrs. Jackson and Simone (Chairman). The Board has determined that all members of the Audit Committee are financially literate as that term is defined by NASDAQ and by applicable SEC rules. The Board has determined that each of Ms. Bayless and Messrs. Jackson and Simone is an “audit committee financial expert” as defined by applicable SEC rules. During 2018, the Audit Committee met six times.
Compensation Committee. The Compensation Committee sets the compensation levels of senior management and administers Veeco’s equity compensation plans. All members of the Compensation Committee are “non-employee directors” (within the meaning of Rule 16b‑3 of the Exchange Act), and “outside directors” (within the meaning of Section 162(m) of the Internal Revenue Code of 1986, as amended). None of the members of the Compensation Committee has interlocking relationships as defined by the SEC. The Compensation Committee consists of Messrs. D’Amore, St. Dennis and Hunter (Chairman). During 2018, the Compensation Committee met seven times.
8
Governance Committee. The Company’s Governance Committee addresses Board organizational issues and develops and reviews corporate governance principles applicable to Veeco. In addition, the committee searches for persons qualified to serve on the Board of Directors and makes recommendations to the Board with respect thereto, as more fully described below. The Governance Committee is comprised entirely of independent directors, as defined by the NASDAQ listing standards, and currently consists of Messrs. Hunter, Simone and Jackson (Chairman). During 2018, the Governance Committee met four times.
Board Composition and Nomination Process
Pursuant to our Corporate Governance Guidelines, the Governance Committee will evaluate the suitability of potential nominees for membership on the Board, taking into consideration the Board’s current composition, including expertise, diversity and balance of inside, outside and independent directors, and considering the general qualifications of the potential nominees, including those characteristics described in the Corporate Governance Guidelines as in effect from time to time. In selecting the director nominees, the Board endeavors to establish a diversity of background and experience in a number of areas of core competency, including business judgment, management, accounting and finance, knowledge of the industries in which the Company operates, understanding of manufacturing and services, strategic vision, knowledge of international markets, marketing, research and development and other areas relevant to the Company’s business. Under our Corporate Governance Guidelines, the Board periodically conducts a critical self-evaluation, including an assessment of the make-up of the Board as a whole. In any particular situation, the Governance Committee may focus on persons possessing a particular background, experience or qualifications which the committee believes would be important to enhance the effectiveness of the Board. The full Board reviews and has final approval authority on all potential director candidates being recommended to the stockholders for election.
Veeco’s Director Compensation Policy provides that members of the Board of Directors who are not employees of Veeco shall be paid a quarterly retainer in the amount of $17,500. Additional quarterly retainers are paid for committee membership, as follows:
Board Committee |
Quarterly |
Quarterly |
Audit |
2,500 |
5,000 |
Compensation |
1,875 |
3,750 |
Governance |
1,250 |
2,500 |
A quarterly retainer in the amount of $5,125 is paid for service as the Lead Director. Board members do not receive fees for attending meetings either in person or telephonically.
Each non-employee Director shall also receive an annual grant of shares of restricted stock having a fair market value in the amount determined by the Compensation Committee from time to time. For 2018, the Compensation Committee determined that the value of this annual award should be $120,000 per director. The restrictions on these shares lapse on the earlier of the first anniversary of the date of grant and the date immediately preceding the date of the next annual meeting of stockholders. In addition, the Company’s Director Compensation Policy gives the Board the authority to compensate directors who perform significant additional services on behalf of the Board or a Committee. Such compensation is to be determined by the Board in its discretion, taking into consideration the scope and extent of such additional services. The Company is currently seeking stockholder approval to amend and restate the Veeco 2010 Stock Incentive Plan to, among other things, limit Director compensation to $400,000 per year (see Proposal 2 below for proposed changes to Veeco’s 2010 Stock Incentive Plan). Directors who are employees, such as Dr. Miller and Mr. Peeler, do not receive additional compensation for serving as directors.
9
The following table provides information on compensation awarded or paid to the non-employee directors of Veeco for the fiscal year ended December 31, 2018.
|
Fees Earned |
Stock |
All Other |
|
|
or Paid in |
Awards |
Compensation |
|
Name |
Cash ($)(1) |
($)(2)(3) |
($) |
Total ($) |
Kathleen A. Bayless |
80,000 |
119,995 |
— |
199,995 |
Richard A. D’Amore |
98,000 |
119,995 |
— |
217,995 |
Gordon Hunter |
90,000 |
119,995 |
— |
209,995 |
Keith D. Jackson |
90,000 |
119,995 |
— |
209,995 |
Peter J. Simone |
95,000 |
119,995 |
— |
214,995 |
Thomas St. Dennis |
77,500 |
119,995 |
— |
197,495 |
(1) |
Represents the sum of quarterly retainers paid for Board service during 2018. |
(2) |
Reflects awards of 7,643 shares of restricted stock to each director on May 4, 2018. These restricted stock awards vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the date immediately preceding the date of the next annual meeting of stockholders. In accordance with SEC rules, the amounts shown reflect the grant date fair value of the award, which was $15.70 per share. |
(3) |
As of December 31, 2018, there were outstanding the following aggregate number of stock awards and option awards held by each non-employee director of the Company: |
Outstanding Equity Awards at Fiscal Year End |
||
|
Stock |
Option |
Name |
Awards (#) |
Awards (#) |
Kathleen A. Bayless |
7,643 |
— |
Richard A. D’Amore |
7,643 |
— |
Gordon Hunter |
7,643 |
— |
Keith D. Jackson |
7,643 |
— |
Peter J. Simone |
7,643 |
— |
Thomas St. Dennis |
7,643 |
— |
Stock Ownership Guidelines: Directors
Under the Company’s Stock Ownership Guidelines, Directors are required to hold Veeco stock with a value equal to at least three times the Directors’ annual cash retainers (excluding retainers for committee or lead director service), measured as of February 1st of the most recently completed year and subject to a 5‑year phase-in period.
Certain Contractual Arrangements with Directors and Executive Officers
Veeco has entered into indemnification agreements with each of its directors, executive officers and certain senior officers and anticipates that it will enter into similar agreements with any future directors and executive officers. Generally, the indemnification agreements are designed to provide the maximum protection permitted under Delaware law with respect to indemnification of a director or executive officer. The indemnification agreements provide that Veeco will indemnify such persons against certain liabilities that may arise by reason of their status or service as a director or executive officer of the Company and that the Company will advance expenses incurred as a result of proceedings against them as to which they may be indemnified. Under the indemnification agreements, a director or executive officer will receive indemnification if he or she is found to have acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of Veeco and with respect to any criminal action, if he or she had no reasonable cause to believe his or her conduct was unlawful.
10
The executive officers of Veeco, their ages and positions as of March 11, 2019, are as follows:
Name |
Age |
Position |
William J. Miller, Ph.D. |
50 |
Chief Executive Officer |
John R. Peeler |
64 |
Executive Chairman and former Chief Executive Officer |
Shubham Maheshwari |
47 |
Executive Vice President, Chief Financial Officer and Chief Operating Officer |
John P. Kiernan |
56 |
Senior Vice President, Finance, Chief Accounting Officer and Treasurer |
William J. Miller, Ph.D. has been CEO and a Director since October 2018. Prior thereto, he served as President beginning in January 2016, overseeing all of Veeco’s global business units. Dr. Miller was named Executive Vice President, Process Equipment in December 2011, and was Executive Vice President, Compound Semiconductor from July 2010 until December 2011. Dr. Miller was Senior Vice President and General Manager of Veeco’s MOCVD business from January 2009 to July 2010, and Vice President, General Manager of Veeco’s Data Storage equipment business from January 2006 to January 2009. He has held leadership positions of increasing responsibility in both the engineering and operations organizations since he joined Veeco in November 2002. Prior to joining Veeco, Dr. Miller held engineering and operations leadership positions at Advanced Energy Industries, Inc.
John R. Peeler has been Executive Chairman since October 2018. Prior thereto, he served as CEO and a Director beginning in July 2007, and as Chairman beginning in May 2012. Before coming to Veeco, Mr. Peeler was Executive Vice President of JDS Uniphase Corp. (“JDSU”) and President of the Communications Test & Measurement Group of JDSU, which he joined upon the closing of JDSU’s merger with Acterna in August 2005. Before joining JDSU, Mr. Peeler served as President and CEO of Acterna. Mr. Peeler joined a predecessor of Acterna in 1980 and served in a series of increasingly senior leadership roles including Vice President of Product Development, Executive Vice President and COO, and President and CEO of TTC, a communications test equipment company. Mr. Peeler also serves on the board of IPG Photonics Corporation.
Shubham (Sam) Maheshwari has been Executive Vice President, CFO and COO since October 2018. Prior thereto, he served as Executive Vice President and CFO beginning in May 2014. Mr. Maheshwari oversees Veeco’s Quality, Customer Satisfaction, Business Process Improvement, Legal, Finance, Investor Relations, Information Technology, Supply Chain and Global Manufacturing functions. From 2011 to 2014, Mr. Maheshwari served as CFO of OnCore Manufacturing LLC, a global manufacturer of electronic products in the medical, aerospace, defense and industrial markets. From 2009 to 2011, he held various finance roles including Senior Vice President Finance, Treasury, Tax and Investor Relations at Spansion, Inc., a global leader in flash memory based embedded system solutions. Mr. Maheshwari helped lead Spansion’s emergence from bankruptcy to become a successful public company. From 1998 to 2009, he was with KLA-Tencor Corporation, a global semiconductor capital equipment manufacturing company, in various senior level corporate development and finance roles, including Vice President of Corporate Development and Corporate Controller. Mr. Maheshwari also serves on the board of Kateeva, Inc.
John P. Kiernan has been Senior Vice President, Finance, Chief Accounting Officer (“CAO”) and Treasurer since December 2011, and also served as Corporate Controller from December 2011 through December 2017. From July 2005 to November 2011, Mr. Kiernan was Senior Vice President, Finance, CAO and Corporate Controller. Prior thereto, he was Vice President, Finance and Corporate Controller of Veeco from April 2001 to June 2005, Vice President and Corporate Controller from November 1998 to March 2001, and Corporate Controller from February 1995 to November 1998. Prior to joining Veeco, Mr. Kiernan was an Audit Senior Manager at Ernst & Young LLP from October 1991 through January 1995 and held various audit staff positions with Ernst & Young LLP from June 1984 through September 1991.
11
Compensation Discussion and Analysis
This Compensation Discussion and Analysis describes Veeco’s current compensation programs and policies, which are subject to change.
Business Summary and Recent Developments
Veeco is a leading manufacturer of innovative semiconductor and thin film process equipment used by our customers to solve an array of challenging materials engineering problems. Our broad portfolio of metal organic chemical vapor deposition (“MOCVD”), molecular beam epitaxy (“MBE”), lithography, laser annealing, ion beam and single wafer etch and clean technologies play an integral role in the fabrication and packaging of advanced semiconductor and compound semiconductor devices including in the production of light emitting diodes (“LEDs”) for solid-state lighting and display, lasers for communications and 3D sensing, radio frequency (“RF”) devices and application processors for mobile phones and thin film magnetic heads for hard disk drives. We design our systems to optimize technical performance and productivity to achieve superior cost of ownership for our customers. We support our products through sales and service teams located throughout the Asia-Pacific region, Europe and North America.
Veeco holds technology leadership positions in each of our served markets. However, the semiconductor and thin film process equipment industries are highly cyclical and characterized by periods of volatility which may be difficult to predict. Our products require significant R&D investment sustained over very long periods of time and our customers’ buying decisions are highly dependent on technology trends and industry supply and demand patterns. Our executive compensation programs are designed to align with such market conditions, to balance both the short and long-term interests of stockholders and executives and, at the same time, retain and continue to attract executives through business downturns, motivating them for our longer-term success.
The Company seeks to foster a performance-oriented culture by linking a significant portion of each executive’s compensation to the achievement of performance targets important to the success of the Company and its stockholders. We structure our executive compensation program each year so that a meaningful percentage of compensation is tied to the achievement of objectives that, at the time they are established, are considered challenging in light of anticipated market conditions.
2018 Business Highlights and Challenges
· |
We have begun to transition the Company’s MOCVD business to the broader compound semiconductor market with the development of new products for photonics, RF and power electronics applications. Our success depends on our ability to win market share and on the adoption of certain technologies by our customers. |
· |
We also increased our focus on mainstream semiconductor market opportunities. We achieved early success with wins in leading edge nodes for laser annealing products and orders for our extreme ultraviolet (“EUV”) mask blank deposition systems. |
· |
We reduced costs as the MOCVD market for LEDs in China became commoditized and our Advanced Packaging business remained weak due to smartphone supply chain softness. |
· |
Notwithstanding improvements related to product mix, gross margins remain below expectations due to lower shipment volume run-rates. |
· |
We were required to record two significant, non-cash asset impairment charges. In the second quarter of 2018, the Company lowered its projected results for the Ultratech product lines. As a result, the Company recorded a non-cash impairment charge of $252 million. Additionally, as a result of the significant decline in the Company’s stock price during the fourth quarter of 2018, we were required to record a non-cash goodwill impairment charge of $123 million. |
· |
We repurchased approximately 950,000 shares of common stock through our Board-approved stock buyback program representing approximately 75% of the shares awarded to executives in 2018. |
12
· |
In early 2019, our stock price increased approximately 50%, reflecting growing confidence in our Company. While this is encouraging, we are not satisfied with the current price and are committed to further increases in shareholder value. |
Executive Leadership Team Changes
The Company made changes to its executive leadership team during 2018. John Peeler, Chairman and CEO, retired from the position of CEO effective September 30, 2018. In conjunction with the Company’s established CEO succession plan, Mr. Peeler agreed to serve as Executive Chairman of the Company for one year and to continue as non-executive Chairman thereafter, subject to his re-election to the Board upon expiration of his current term at the 2019 Annual Meeting of Stockholders.
William Miller, Ph.D. succeeded Mr. Peeler as the Company’s CEO, effective October 1, 2018. Prior to being named CEO, Dr. Miller served as President of the Company. Dr. Miller was an integral part of the strategic direction and product development for the Company’s MOCVD and Ion Beam product lines and was responsible for the Company’s global operations organization.
Shubham (Sam) Maheshwari, the Company’s CFO, was appointed to the additional position of COO, also effective October 1, 2018. Mr. Maheshwari joined the Company in 2014 with 20 years of experience in finance. Mr. Maheshwari oversees the Company’s finance, global operations, information technology, quality and customer satisfaction, and legal functions.
2018 / 2019 Executive Compensation Highlights
· |
Our stock price declined significantly during 2018. Our executive compensation plans are designed to align pay with performance. As has consistently been the case, the Compensation Committee (hereinafter the “Committee”) and our executives are fully aligned in the application of negative discretion to reduce or forego compensation even when, under our plan designs, such compensation may have been earned. This was true in 2018 in the case of both equity grants and cash bonus awards and in the determination of 2019 equity grants. For example, although a cash bonus was earned under the 2018 Management Bonus Plan, management and the Committee agreed to cancel the plan and no awards were paid. |
· |
Shareholders have expressed, through our outreach, a desire for greater transparency around long-term compensation performance metrics. In response, beginning in October 2018, we discontinued the use of internal metrics in our performance-based equity awards in favor of relative total shareholder return (“TSR”) as compared to the Russell 2000 Index (“R2000”) over a three-year period. Promotion grants to our new CEO and CFO/COO in October 2018 were comprised of at least 75% of such performance-based awards. |
· |
In 2019, the majority of equity awards to our NEOs will be similarly comprised of performance-based equity awards subject to adjustment, including complete forfeiture, based on the Company’s three-year TSR as compared to the R2000. In March 2019, the Committee determined that the 2019 equity awards to our NEOs will be split between performance-based restricted stock units (“PRSUs”) and time-based restricted stock with a ratio of 60% to 40%, respectively. These requirements do not apply to Mr. Peeler, whose compensation is separately addressed in an amendment to his employment agreement with the Company signed in connection with his transition to the role of Executive Chairman. |
· |
The terms of 2019 performance-based equity awards shall include: (1) a negative TSR cap that limits awards to 100% if the Company’s TSR is negative, notwithstanding that the Company’s TSR may be above the 50th percentile of the comparison group, and (2) a maximum award cap that limits the overall dollar value of the earned award to six times the grant value, based on the compound effects of the award payout and the then-current stock price. |
· |
In mid‑2018, in conjunction with our CEO succession plan and when our stock traded at approximately $15.00 per share, the value of 2019 equity awards to our NEOs were established. Ordinarily, the number of shares comprising the 2019 equity awards would be determined based on |
13
the stock price at the time of grant in 2019. However, to ensure that our NEOs do not benefit from the decline in our stock price, the Committee proposed that the number of shares awarded to the NEOs for 2019 be determined on the basis of the higher of the stock price at the grant date and $15.00 per share. This application of negative discretion has the effect of reducing the value of 2019 equity awards to our NEOs. |
· |
In conjunction with his promotion to CEO, Dr. Miller received an equity award with a grant date fair market value equal to $2.5 million, 80% of which was granted as a PRSU and is therefore subject to full forfeiture. Dr. Miller’s 2018 compensation, including this promotion grant, is incorporated in shareholder advisor pay-for-performance calculations comparing pay to total shareholder return. The illustration below characterizes Dr. Miller’s compensation both with the value of the promotion grant (“2018 w/ Promotion Equity”) and without the value of the promotion grant (“2018 w/o Promotion Equity”), and in the latter case, reflects compensation that is much more in line with our performance as measured by TSR. |
· |
Lastly, we are proposing several amendments to our 2010 Stock Incentive Plan in conjunction with current best practices, including: (1) specifying the treatment of performance-based equity awards on a change in control; (2) including equity in our clawback policy; (3) establishing a limit on annual compensation to non-employee directors; and (4) specifying the treatment of dividends on unvested awards. See Proposal 2 below for a full description of the proposed changes to the 2010 Stock Incentive Plan. |
Executive Compensation Strategy and Objectives
The Company’s executive compensation strategy is designed to create opportunities for competitive, total compensation that reflects our culture, the markets we serve and our performance. The primary objective of the executive compensation strategy is to motivate executives to achieve long-term growth and success for the Company, including increasing stockholder value, without subjecting the Company or stockholders to unnecessary or unreasonable risks. The Company’s executive compensation programs are also essential to
14
our ability to attract and retain executives. Accordingly, the Company has adopted the following guiding principles:
Performance-based: |
Compensation levels should be determined based on Company financial performance and individual results, each as compared to quantitative and qualitative performance priorities set at the beginning of the performance period. The ratio of performance-based compensation to fixed compensation shall increase with the level of the executive, with the greatest amount of performance-based compensation at the CEO level. Performance-based compensation should be subject to a complete risk of forfeiture.
|
Stockholder-aligned: |
A significant portion of potential compensation should be performance- and time-based equity to more closely align the interests of executives with those of our stockholders.
|
Fair and Competitive: |
Compensation levels should be fair, internally and externally, and competitive with overall compensation levels at other companies with which we compete for talent. Our compensation programs should promote our ability to both attract and retain our employees, including our executives. |
Our target pay mix places significant emphasis on variable compensation comprised of PRSU awards1, time-based equity awards and an annual target bonus. As illustrated in the following charts, 87% and 76% of the target compensation packages for our CEO and our other NEOs, respectively, are comprised of equity-based and performance-based compensation.
CEO Compensation Elements* |
Other NEO Compensation Elements* |
|
|
*Includes October 2018 promotion equity awards to Dr. Miller and Mr. Maheshwari.
1 Beginning in October 2018, based on 3‑year relative total shareholder return as compared to the Russell 2000 Index.
15
Executive Compensation Governance and Procedures
The Committee administers the Company’s compensation programs operating under a charter adopted by the Board. This charter authorizes the Committee to administer and interpret the Company’s compensation and equity plans and establish rules for their implementation and administration. The Committee consists of three independent directors who are appointed annually. The Committee works closely with the CEO and the Senior Vice President, Human Resources and relies on information provided by independent compensation consultants.
When making compensation decisions, the Committee considers the compensation practices and the competitive market for executives at companies with which we compete for talent. To this end, the Company utilizes several resources which, during 2018, included: meetings with Compensation Strategies, Inc., an independent compensation consultant; compensation surveys prepared by Radford; and executive compensation information compiled by Compensation Strategies, Inc. from the proxy statements of other companies, including a peer group.
Veeco’s peer group (the “Peer Group”) reflects the companies that closely resemble Veeco based on industry and competition for talent, and that closely align with Veeco’s market segments and size. The 2018 Peer Group consisted of the following seventeen companies:
3D Systems Corporation |
MACOM Technology Solutions |
Advanced Energy Industries, Inc. |
MKS Instruments, Inc. |
Badger Meter, Inc. |
OSI Systems, Inc. |
Brooks Automation, Inc. |
Photronics, Inc. |
Cabot Microelectronics Corporation |
Pure Storage, Inc. |
Cray Inc. |
Rudolph Technologies, Inc. |
Entegris, Inc. |
Semtech Corporation |
FormFactor, Inc. |
Xperi Corporation |
In July 2018, consistent with its periodic review, the Committee updated the Peer Group by removing two companies and adding ten companies based on industry segment (comprised of Semiconductor Equipment, Technology/Hardware, Storage & Peripherals and Electronic Equipment & Instruments) and, within segment, revenue within a range of 0.5x – 3.0x. This resulted in the 2019 Peer Group, consisting of the following 25 companies:
3D Systems Corporation |
OSI Systems, Inc. |
Advanced Energy Industries, Inc. |
Photronics, Inc. |
Axcelis Technologies, Inc. |
Power Integrations, Inc. |
Badger Meter, Inc. |
Pure Storage, Inc. |
Brooks Automation, Inc. |
Rambus Inc. |
Cabot Microelectronics Corporation |
Rudolph Technologies, Inc. |
Cohu, Inc. |
Semtech Corporation |
Cray Inc. |
SolarEdge Technologies, Inc. |
Entegris, Inc. |
Ultra Clean Holdings, Inc. |
FormFactor, Inc. |
Versum Materials, Inc. |
Kulicke and Soffa Industries, Inc. |
Xcerra Corporation |
Monolithic Power Systems, Inc. |
Xperi Corporation |
Nanometrics Incorporated |
|
The Company considers the executive compensation practices of the companies in its Peer Group and the Radford survey (hereinafter collectively, the “market data”) as one of several factors used in setting compensation. The Company’s compensation consultant uses statistical regression techniques to adjust market data to construct market pay levels representative of the 50th - 75th percentile that are reflective of Veeco’s size based on revenues. Although the Committee considers the executive compensation practices of the Peer Group companies and broader market data in setting compensation, it does not benchmark compensation to any specific percentile or ranking within our Peer Group. Individual compensation levels may
16
vary within a range around market as a result of Veeco’s financial and operating performance, personal performance, experience, and criticality, as well as competitive factors.
For 2018, total target compensation of Veeco’s NEOs and other executives was generally below the 50th percentile of market. Given the performance emphasis present in Veeco’s executive compensation program, actual compensation earned or received can vary significantly with results and actual compensation for 2018 was well below targeted opportunity levels.
In addition to reviewing the market data, the Committee meets with the Company’s CEO and Senior Vice President, Human Resources to consider recommendations with respect to compensation for the NEOs and other executives. These recommendations include base salary levels, cash bonus targets and awards, and equity compensation awards. The Committee considers these recommendations along with other factors in determining specific compensation levels for the NEOs. The Committee discusses the elements of the CEO’s compensation with him, but makes the final decisions regarding his compensation without him present.
Decisions regarding the Company’s compensation program elements are made by the Committee in regularly scheduled and ad hoc meetings. Issues of significant importance are frequently discussed over several meetings. This practice provides the Committee with the opportunity to raise and address concerns before arriving at a decision. Prior to each meeting, Committee members are provided with the written materials, information and analyses as may be required to assist the Committee in its decision-making process. To the extent possible, meetings of the Committee are conducted in person. When this is not possible, meetings are conducted telephonically. The CEO and the Senior Vice President, Human Resources are regularly invited to attend Committee meetings but the Committee meets privately in executive sessions to consider certain matters including, but not limited to, the compensation of the CEO.
17
Elements of Our Executive Compensation Program
Our compensation programs are comprised of four elements: base salary, annual cash bonus, equity-based compensation and benefits and perquisites. Each of these elements is used to attract executives and reward them for performance results as described in the following table:
Element |
|
Description / Characteristics |
|
Primary Objectives |
Base Salary |
|
Annual cash compensation |
|
Attract and retain highly qualified talent Provides a regular source of income at market-competitive levels |
Annual Cash Incentive |
|
100% performance-based cash compensation opportunity Mix of annual financial and individual goals Awards range from 0% to 200% of targets established for each executive |
|
Align executive compensation with annual goals important to the success of the Company Promote a pay-for-performance culture with an “at risk” opportunity for compensation tied directly to performance |
|
|
|
|
|
Equity-based Compensation |
|
Performance-based awards constituting the majority of awards to NEOs; earned over a 3‑year performance period Time-based awards vesting over a 4‑year period Subject to forfeiture |
|
Incentivize long-term performance Serve as a retention incentive Align the interests of executives with stockholders in the creation of long-term value Foster a culture of stock ownership |
|
|
|
|
|
Benefits & Perquisites |
|
Senior Executive Change in Control Policy Company-subsidized health and welfare benefits 401(k) savings plan Employee Stock Purchase Plan |
|
Encourage executives to act in the best interests of stockholders Promote productivity, remain competitive, and increase employee loyalty to the Company |
The Company evaluates each element of each executive’s compensation individually and in the aggregate against market data for the position, experience, individual performance and the ability to affect future Company performance. The following sections describe the process for determining each of the four elements of the executive compensation program.
(i) Base Salary
The Company pays base salaries to attract and retain executives. Base salaries are determined in accordance with the responsibilities of each executive, market data for the position and the executive’s experience and individual performance. The Company considers each of these factors but does not assign a specific value to any one factor.
Base salaries for executives are typically set during the first half of the year in conjunction with the Company’s annual performance management process. In 2018, base salaries were initially set in April. The base salaries for certain NEOs were adjusted in October 2018 as part of changes in the Company’s executive leadership
18
team. Following a review of the market data and management’s recommendations, the Committee set base salaries as follows in April 2018 and, following changes in the executive team, in October 2018:
Name |
April |
April |
Percent |
October |
Percent |
W. Miller(1) |
$474,000 |
$500,000 |
5.5% |
$575,000 |
15% |
J. Peeler(2) |
$700,000 |
$700,000 |
n/a |
$500,000 |
‑28.6% |
S. Maheshwari(1) |
$443,000 |
$460,000 |
3.8% |
$500,000 |
8.7% |
J. Kiernan(3) |
$300,000 |
$310,000 |
3.3% |
$310,000 |
n/a |
(1) |
In April 2018, base salaries for Dr. Miller and Mr. Maheshwari were increased 5.5% and 3.8%, respectively, in conjunction with the Company’s annual salary planning process. In October 2018, base salaries for Dr. Miller and Mr. Maheshwari were increased by 15% and 8.7%, respectively, in connection with their promotions. |
(2) |
Mr. Peeler’s base salary had not been increased since April 2011. In October 2018, in conjunction with his transition to Executive Chairman, Mr. Peeler’s base salary was reduced by $200,000. |
(3) |
In April 2018, Mr. Kiernan’s base salary was increased by 3.3% in conjunction with the Company’s annual salary planning process. |
(ii) Cash Bonus Plan
The Company provides the opportunity for cash bonuses under its annual bonus plan to attract executives and reward them for performance consistent with the belief that a significant portion of the compensation of its executives should be performance-based. As a result, individuals are compensated based on the achievement of specific financial and individual performance goals intended to correlate closely with stockholder value. The Company believes that the opportunity to earn cash bonuses motivates executives to meet Company performance objectives that, in turn, are linked to the creation of stockholder value. The Company utilizes profitability, as measured by adjusted operating income, as the financial element of its bonus plan. Executives must generally be employed at the time awards are paid to be eligible to receive a bonus for that period.
On February 6, 2018, the Committee approved the 2018 Management Bonus Plan (the “2018 Plan”) and the specific metrics thereof. The 2018 Plan is based on the financial performance of the Company as measured by adjusted operating income (“Operating Income”). We define Operating Income as earnings before the cost of bonuses, interest, taxes and amortization, adjusted to exclude share-based compensation expense, one-time charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs and the stepped-up cost of goods sold associated with the purchase accounting of acquired inventory.
The Committee elected to use Operating Income as the financial metric for the 2018 Plan because it closely aligns operating performance to earnings per share, a key driver of shareholder value. If 2018 Operating Income exceeds $15 million (the threshold performance level), a bonus pool would be funded with a fixed percentage of Operating Income. The bonus pool would not be funded and bonus awards would not be earned if Operating Income results are less than the threshold performance level. Awards to participants would be made from this fixed pool in accordance with their target bonus amounts. 25% of a participant’s target bonus, after adjustment for Operating Income results, would be adjusted based on individual performance. Awards for individual performance would be paid from this fixed pool, ranging from zero to 150%.
The total bonus award for an individual is capped at 200% of target bonus.
During the third quarter of 2018, management recommended to the Committee that the 2018 Plan be cancelled based on the financial outlook for the year. Based on this recommendation and notwithstanding that the Plan’s primary financial metric, Operating Income, was expected to exceed the threshold performance level ($15 million), the Committee agreed with management and the 2018 Plan was cancelled.
19
Had this negative discretion not been applied, bonus awards of approximately 37% of target would have been earned. To the extent calculated, below are components of the bonuses that were foregone:
Name |
Target |
Financial |
Individual |
Final |
W. Miller1 |
$533,125 |
$198,323 |
n/a |
$0 |
J. Peeler1 |
$728,750 |
$271,095 |
n/a |
$0 |
S. Maheshwari1 |
$388,500 |
$144,522 |
n/a |
$0 |
J. Kiernan |
$155,000 |
$57,660 |
n/a |
$0 |
(1) |
Target bonus amounts are prorated to reflect October 2018 salary and target bonus changes. |
(2) |
In light of the cancellation of the 2018 Plan, the individual performance target and award amounts were not calculated. |
On February 6, 2019, the Committee approved the 2019 Management Bonus Plan (the “2019 Plan”). Under the 2019 Plan, bonuses will be based on the financial performance of the Company as measured by Operating Income. If 2019 Operating Income exceeds $15.0 million, the threshold financial performance, a bonus pool will be funded with a predetermined fixed percentage of Operating Income. The bonus pool will not be funded and bonus awards will not be earned if Operating Income is less than $15.0 million. Awards to participants will be made from this fixed pool in accordance with their target bonus amounts. 25% of a participant’s target bonus, adjusted for Operating Income results, will be modified based on individual performance. Awards for individual performance will be paid from this fixed pool and may range from zero to 150%.
Under the 2019 Plan, target bonus awards will only be earned when Operating Income significantly exceeds the 2019 business plan. The total bonus award for an individual will be capped at 200% of target bonus.
Target bonuses for each of the NEOs, expressed as a percent of base salary are as follows:
Name |
January 2018 |
October 2018 |
January 2019 |
W. Miller1 |
100% |
110% |
110% |
J. Peeler2 |
115% |
100% |
100% |
S. Maheshwari1 |
80% |
90% |
90% |
J. Kiernan |
50% |
50% |
50% |
(1) |
In October 2018, the target bonuses for Dr. Miller and Mr. Maheshwari were increased in conjunction with their promotions. |
(2) |
Mr. Peeler’s target bonus was reduced in October 2018 in conjunction with his transition to Executive Chairman. |
(iii) Equity-Based Compensation
The Company believes that a substantial portion of an executive’s compensation should be awarded in equity since equity-based compensation is directly linked to stockholder interests. Equity awards vest over time, subject to being earned in the case of performance-based awards and to the recipient’s continued employment, therefore acting as both a significant performance and retention incentive. Equity awards also help create stock ownership among the Company’s executives. The Committee believes that the majority of long-term incentives for higher-level executives including the NEOs should take the form of performance-based equity compensation and is committed to this principle.
20
The Company granted equity-based awards to the NEOs and certain other key employees in 2018 to create a clear and meaningful alignment between compensation and stockholder return. These awards included restricted stock and performance-based restricted stock units.
The Company considered several factors in the design of the 2018 equity award process. Long-term incentive compensation guidelines, denominated as a dollar value and based on the market data (as discussed above), were developed for each of the NEOs and the other executives. Stock awards were valued at fair market value and not adjusted to reflect the impact of vesting or accounting valuation.
The actual value of stock awards granted to each individual was based on several factors including, but not limited to: (i) the Company’s guidelines (as described above), (ii) the individual’s level of responsibility, (iii) past performance and ability to affect future Company performance, (iv) noteworthy achievements and (v) a fixed budget for awards. The CEO used these factors to arrive at a recommendation for each of the NEOs. This recommendation was divided into performance- and time-based awards, such that a majority of the award was designated as performance-based. The CEO then discussed the rationale for his recommendations with the Committee. The CEO presented the final recommendations to the Committee for approval.
2018 Annual Awards
On March 14, 2018, the Committee determined that the appropriate values of annual equity awards for Dr. Miller and Mr. Maheshwari were $1,100,000 and $750,000, respectively. At that time, however, the Committee decided to grant equity awards to Dr. Miller and Mr. Maheshwari valued at approximately $880,000 and $600,000, respectively. The Committee agreed to consider granting the balance of the equity awards at the end of the year subject to a review of Company performance (including total shareholder return and other financial metrics) and individual performance. The March 2018 awards were split into performance- and time-based restricted stock with a ratio of approximately 51% to 49%, respectively; see discussion regarding “Performance-based Restricted Stock Unit Awards” below. The Committee also approved an equity award package to Mr. Kiernan in the amount of approximately $200,000, with a performance-based to time-based ratio of 51% to 49%.
In December 2018, based on a review of Company performance and at Mr. Peeler’s recommendation, the Committee elected to forego granting any portion of the balance of the equity awards previously approved for, but not granted to, Dr. Miller and Mr. Maheshwari in March 2018. As a result, Dr. Miller and Mr. Maheshwari were awarded equity compensation in the amounts of approximately $880,000 and $600,000, respectively, and forwent the remaining $230,000 and $150,000 of their annual equity awards, respectively.
The Committee determined Mr. Peeler’s 2018 equity award in conjunction with an analysis of his total compensation package, a review of market data and his performance during 2018 and a review of the stockholder advisor quantitative pay-for-performance methodology. The Committee reviewed a tally sheet setting forth the components of compensation for Mr. Peeler, including base salary, annual incentive bonus, prior stock option and restricted stock grants, potential stock option and restricted stock gains, and the dollar value to Mr. Peeler and cost to the Company of all perquisites and other personal benefits. Based on its review, the Committee concluded that Mr. Peeler’s compensation, in the aggregate, is reasonable and appropriate in light of our desire to retain him, the stated objectives of the Company’s compensation programs and the Company’s financial and operating performance. The Committee approved an equity award to Mr. Peeler valued at approximately $1,685,800, and granted equity valued at approximately $1,000,000, which was split into performance- and time-based restricted stock with a ratio of 51% to 49%, respectively (see discussion regarding “Performance-based Restricted Stock Unit Awards” below). The Committee agreed to consider granting the balance of the award, approximately $685,800, at the end of the year, subject to a review of Company performance (including total shareholder return and other financial metrics) and individual performance.
In December 2018, based on a review of Company performance and at Mr. Peeler’s recommendation, the Committee elected to forego granting any portion of the balance of the equity award approved for, but not previously granted to, Mr. Peeler. As a result, Mr. Peeler’s 2018 equity-based compensation was approximately $1,000,000, and he forwent the remaining $685,800 in awards.
21
Mr. Peeler’s performance-based and time-based restricted stock awards carry the same terms as awards granted to the other NEOs, as described below.
During 2018, the Committee granted equity awards to the NEOs specifically as follows:
|
|
Performance-based Restricted Stock |
Time-based Restricted Stock |
||||
Name |
Date of |
Amount |
Fair |
Total |
Amount |
Fair |
Total Value |
W. Miller |
03/14/2018 |
22,724 |
$19.75 |
$448,799 |
21,832 |
$19.75 |
$431,182 |
|
10/01/2018 |
195,121 |
$10.25 |
$1,999,9901 |
48,780 |
$10.25 |
$499,995 |
J. Peeler |
03/14/2018 |
25,822 |
$19.75 |
$509,984 |
24,810 |
$19.75 |
$489,997 |
S. Maheshwari |
03/14/2018 |
15,493 |
$19.75 |
$305,986 |
14,886 |
$19.75 |
$293,999 |
|
10/01/2018 |
73,170 |
$10.25 |
$749,9921 |
24,390 |
$10.25 |
$249,997 |
J. Kiernan |
03/14/2018 |
5,164 |
$19.75 |
$101,989 |
4,962 |
$19.75 |
$97,999 |
(1) |
Reflects the grant date fair market value of the target number of shares subject to the award and not the grant date fair value as determined under generally accepted accounting principles, which is reflected in the Summary Compensation Table. |
Performance-based Restricted Stock Unit Awards
A majority of the annual long-term incentive awards granted in 2018 may be earned subject to the achievement of designated performance criteria. If the applicable performance criteria are not achieved within the designated time, the PRSU awards granted to the NEOs will be completely forfeited.
March 2018 PRSU Award Terms
One-half of the PRSUs may be earned based on three-year cumulative revenue (the “Revenue Units”) and one-half of the PRSUs may be earned based on three-year cumulative adjusted EBITDA (the “EBITDA Units”), expressed as a percentage of cumulative revenue for the same period, each based on a target performance period of three years. We use cumulative targets because they encourage our executives to focus on longer-term targets that will serve to benefit shareholders over a period of years, rather than simply focusing on a series of shorter-term results. Up to an additional 50% of Revenue Units and EBITDA Units may be earned as a result of exceeding the respective targets. We define adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, adjusted to exclude share-based compensation expense, one-time charges relating to restructuring initiatives, non-cash asset impairments, certain other non-operating gains and losses, and acquisition-related items such as one-time transaction costs and the stepped-up cost of goods sold associated with the purchase accounting of acquired inventory.
The Revenue Units will be earned if the cumulative revenue targets established at the beginning of the performance period are met as shown below. The performance period will span the three-year period from the second quarter of 2018 through the first quarter of 2021. Any Revenue Units that are not earned will be forfeited.
Performance |
Percentage of |
Maximum |
150% |
Target |
100% |
Threshold |
25% |
Below Threshold |
0% |
(1) |
With linear interpolation between cumulative revenue targets to apply. |
22
The number of EBITDA Units earned will be determined pursuant to the following schedule based on adjusted EBITDA as a percent of cumulative revenue for the performance period from the second quarter of 2018 through the first quarter of 2021. Any EBITDA Units that are not earned will be forfeited.
Adjusted |
Percentage of EBITDA |
15% or more |
150% |
14% |
140% |
13% |
130% |
12% |
120% |
11% |
110% |
10% |
100% |
9% |
90% |
8% |
80% |
7% |
70% |
6% |
60% |
5% |
50% |
<5% |
0% |
(1) |
With linear interpolation between Adjusted EBITDA percentages to apply. |
Performance against the cumulative revenue target and the cumulative adjusted EBITDA target will be assessed upon the filing of the Form 10‑Q for the first quarter of 2021, three years after the grant date. The EBITDA and Revenue Units earned will be determined at that time with awards ranging from 0% to 150%.
October 2018 Promotion Awards
In October 2018, the Company granted Dr. Miller an equity award in connection with his promotion to CEO. The equity award consisted of an approximately $2,000,000 PRSU grant which was subject to the Company’s 3‑year TSR versus the 3‑year TSR of the Russell 2000 Index (“Miller TSR Award”) (as further described below), and an approximately $500,000 award which was granted as time-based restricted stock subject to vesting over a four-year period (25% per year) (“Miller Time-Based Award”). The Miller TSR Award and the Miller Time-Based Award were comprised of 195,121 PRSUs and 48,780 restricted stock shares, respectively. A portion of the Miller TSR award (88,457 units) was granted subject to approval by the Company’s stockholders of a proposal to increase the annual individual award limit from 200,000 to 500,000 shares.
In October 2018, Mr. Maheshwari received an equity award in connection with his assumption of the additional role of COO. The equity award consisted of an approximately $750,000 award which was subject to the Company’s 3‑year TSR vs. the 3‑year TSR of the Russell 2000 Index (“Maheshwari TSR Award”) (as further described below), and an approximately $250,000 award which was granted as time-based restricted stock subject to vesting over a four-year period (25% per year) (“Maheshwari Time-Based Award”). The Maheshwari TSR Award and the Maheshwari Time-Based Award consisted of 73,170 PRSUs and 24,390 restricted stock shares, respectively.
The Committee determined the awards to Dr. Miller and Mr. Maheshwari described above pursuant to an analysis of their total compensation and a review of market data. The Committee reviewed the components of compensation, including base salary, annual incentive bonus, equity award, prior stock option and restricted stock grants, and the dollar value to each executive and cost to the Company of all perquisites and other personal benefits. Based on its review, the Committee concluded that the awards to Dr. Miller and Mr. Maheshwari were reasonable and appropriate in light of our desire to motivate and retain them, the stated objectives of the Company’s compensation programs and the Company’s financial and operating performance.
23
The Miller TSR Award and Maheshwari TSR Award may be earned and become vested in accordance with the table below based on the Company’s performance during the period of October 1, 2018 through September 30, 2021. Any units that are not earned will be forfeited.
Performance Range |
Percentile Rank of |
Percentage of Units |
Maximum |
75th Percentile |
200% |
Target |
50th Percentile |
100% |
Threshold |
25th Percentile |
50% |
Below Threshold |
Less than 25th Percentile |
0% |
(1) |
With linear interpolation between Percentile Ranks to apply. |
2019 Annual Awards
The 2019 Awards to our NEOs (other than Mr. Peeler, as addressed above) will be comprised of PRSUs (60%) and time-based restricted stock (40%). The PRSU portion of the 2019 Awards will be earned in accordance with the table below based on the Company’s 3‑year TSR versus the 3‑year TSR of the Russell 2000 Index. Any units that are not earned will be forfeited.
Performance Range |
Percentile Rank of |
Percentage of Units |
Maximum |
75th Percentile |
200% |
Target |
50th Percentile |
100% |
Threshold |
25th Percentile |
50% |
Below Threshold |
Less than 25th Percentile |
0% |
(1) |
With linear interpolation between Percentile Ranks to apply. |
The terms of 2019 PRSU awards shall include: (1) a negative TSR cap that limits awards to 100% if the Company’s TSR is negative, notwithstanding that the Company may be above the 50th percentile of the comparison group, and (2) a maximum award cap that limits the overall dollar value of the earned award to six times the grant value, based on the compound effects of the award payout and the then current stock price. The portion of the 2019 Awards that are time-based restricted stock are subject to vesting over a four-year period.
Pursuant to the terms of Dr. Miller’s, Mr. Peeler’s and Mr. Maheshwari’s August 2018 letter agreements, they are entitled to 2019 equity awards having a grant date fair value of $1,500,000, $1,250,000 and $850,000, respectively.
Ordinarily, the number of shares comprising the 2019 equity awards would be determined based on the stock price at the time of grant in 2019. However, to ensure that our NEOs do not benefit from the decline in our stock price, the Committee proposed that the number of shares awarded to the NEOs for 2019 be determined on the basis of the higher of the stock price at the grant date and $15.00 per share. This application of negative discretion has the effect of reducing the value of 2019 equity awards to our NEOs.
Earned PRSU Awards
On June 12, 2014, the Committee granted PRSUs to the NEOs and other executives that could be earned based on the length of time required to achieve cumulative revenue and EBITDA targets (the “Performance Targets”), each applicable to one half of the award. Under the terms of the grant, 100% of the PRSUs would be earned if the Performance Targets were achieved within three years of the grant date. The number of PRSUs earned would be reduced if the Performance Target is achieved later than three years after the grant date and fully forfeited if the Performance Targets are not achieved within four and one-half years from the grant date.
24
In February 2019, the Committee determined that the cumulative EBITDA target ($135,929,000) was achieved during the third quarter of 2018, four and one-quarter years after the grant date. The number of units earned was reduced by 42% in accordance with the terms of the grant. One-half of the earned units became vested upon such determination; the remaining half shall vest, subject to the executive’s continued service, one year later.
(iv) Benefits and Perquisites
The Company provides the benefits and perquisites to its executive officers that it believes are required to remain competitive, with the goal of promoting enhanced employee productivity and loyalty to the Company. The Committee periodically reviews the levels of benefits and perquisites provided to executive officers. The NEOs participate in the Company’s 401(k) savings plan and other benefit plans on the same basis as other similarly-situated employees. The Company provides a 401(k) savings plan under which it provides matching contributions of fifty cents for every dollar an eligible employee contributes, up to 6% of such employee’s eligible compensation, up to a maximum of $8,250. The plan calls for vesting of Company contributions over the initial five years of a participant’s employment with the Company. The Company also provides group term life insurance for its employees, including the NEOs. The amounts of the Company’s 401(k) matching contributions and group term life insurance premiums for the NEOs are included under the caption “All Other Compensation” in the Summary Compensation Table below. The Company also provides a car allowance for each of the NEOs. Such amounts are also included under the caption “All Other Compensation” in the Summary Compensation Table. The Company does not maintain other perquisite programs, such as post-retirement health and welfare benefits or defined or supplemental pension benefits, for its employees.
In addition, prior to his transition to Executive Chairman, the Company reimbursed Mr. Peeler for his reasonable housing expenses in the Plainview, New York area, and his transportation expenses to/from the Plainview area from/to his home in Maryland (provided that such amounts shall not exceed $75,000 per year). Following Mr. Peeler’s transition to Executive Chairman, he no longer received reimbursement for these items after October 1, 2018. For 2018, the actual expenses associated with Mr. Peeler’s housing and transportation allowance were approximately $27,651 (37% of the maximum). No tax gross-up was provided to Mr. Peeler in connection with this reimbursement.
In 2009, the Company adopted the Senior Executive Change in Control Policy. This policy was designed to provide specified executives, including Dr. Miller and Messrs. Maheshwari and Kiernan, with severance benefits if their employment is terminated under qualifying circumstances related to a change in control. Mr. Peeler is not covered by the Senior Executive Change in Control Policy (see “Potential Payments Upon Termination or Change in Control” below for an explanation of benefits payable to Mr. Peeler in connection with his termination, including in connection with a change in control). The Committee recognizes that, as is the case for most publicly held companies, the possibility of a change in control exists, and the Company wishes to ensure that the NEOs are not disincentivized from discharging their duties with respect to a proposed or actual transaction involving a change in control. Accordingly, through the adoption of the Senior Executive Change in Control Policy, the Company has provided additional inducement for such NEOs to remain in the employ of the Company in the event of a proposed change in control.
Summary of Executive Compensation
The Committee acknowledges that the Company’s financial performance has lagged in certain respects, as reflected in the Company’s lower stock price and reduced stockholder value. The use of performance-based compensation has had the intended effect of reducing compensation for our executives, subjecting them to the same diminished value felt by our stockholders.
Nevertheless, the success of our Company hinges upon our ability to effectively compete for talent. Given the environment in which we operate, the Committee believes that our compensation practices are balanced and competitive and have enabled Veeco to attract and retain the executive talent needed for the successful operation of the Company. The Committee further believes that the total compensation for our NEOs is fair and reasonable and is consistent with the Company’s executive compensation philosophies.
25
Say-on-Pay
Our Board, the Committee and our management value the opinions of our stockholders. We have determined that our stockholders should vote, and do in fact vote, on a say-on-pay proposal on executive officer compensation each year. At the 2016, 2017, and 2018 annual meetings of stockholders, approximately 86%, 76%, and 84% respectively, of votes were cast in favor of our say-on-pay proposal.
Compensation Recoupment Policy
In January 2014, the Company adopted a Compensation Recoupment Policy (the “Clawback Policy”) for certain employees, including the NEOs. Under the Clawback Policy, in the event of a financial restatement due to fraud or intentional illegal conduct as determined by the independent members of the Board, a culpable executive officer may be required to reimburse the Company for performance-based cash compensation if the amount of such compensation would have been lower had it been calculated based on such restated financial statements. In February 2019, the Company revised the Clawback Policy to, among other things, also apply to stock-based awards.
Stock Ownership Guidelines: NEO’s and Other Key Employees
In January 2014, the Company established stock ownership guidelines for certain employees, including the NEOs. Under these guidelines, as amended, each covered individual has five years to reach the minimum levels of stock ownership identified by the Stock Ownership Guidelines.
· |
Veeco’s CEO is required to hold Veeco stock with a value equal to at least six times his base salary (this amount was increased by the Company in March 2019 from four times his base salary); |
· |
Executive Vice Presidents are required to hold Veeco stock with a value equal to at least two times their base salaries; and |
· |
Other covered executive officers are required to hold Veeco stock with a value equal to at least their base salaries. |
Under the guidelines, covered employees are required to hold 50% of the net after tax shares realized upon vesting or exercise until the stock ownership guidelines are met. Participants must maintain compliance once the guidelines have been met, except for the effect of a decrease in stock price in which case they will be required to retain at least 50% of shares acquired upon vesting or exercise until the stock ownership guidelines are again achieved. All of the covered individuals were either in compliance with our Stock Ownership Guidelines or have a period of time remaining to meet the required ownership level.
Anti-Hedging/Anti-Pledging Policy
The Company has adopted an insider trading policy which incorporates anti-hedging and anti-pledging provisions. Consequently, no employee, executive officer or director may enter into a hedge or pledge of the Company’s common stock.
Financial and Tax Considerations
In designing our compensation programs, the Committee considers the financial impact and tax effects that each element of compensation will or may have on the Company and the executives.
Prior to December 22, 2017, when the Tax Cuts and Jobs Act of 2017 (“TCJA”) was signed into law, Section 162(m) of the Internal Revenue Code (“Section 162(m)”) generally limited Veeco’s tax deduction to $1 million per year for compensation paid to certain executive officers, unless the compensation qualified as “performance-based” under Section 162(m).
Under the TCJA, the “performance-based” exception under Section 162(m) was repealed and the $1 million deduction limit generally applies to anyone serving as our CEO or our CFO at any time during a taxable year and our top three other highest compensated executive officers serving at fiscal year-end, as well as to anyone who becomes subject to Section 162(m) in any tax year after 2016, whether or not still serving as an
26
executive officer. These changes generally apply to taxable years beginning after December 31, 2017, but generally do not apply to remuneration provided pursuant to a written binding contract in effect on November 2, 2017, that is not modified in any material respect after that date.
The Committee will continue to monitor developments under Section 162(m), including the impact from the TJCA, but presently intends to retain flexibility to take actions which it deems to be in the best interest of Veeco and its stockholders, even if these actions may result in Veeco paying certain items of compensation that may not be fully deductible.
Conclusion
Attracting and retaining talented and motivated management and key employees is essential to creating long-term stockholder value. Offering a competitive, performance-based compensation program with a substantial equity component helps to achieve this objective by aligning the interests of the executive officers and other key employees with those of our stockholders. We believe that Veeco’s 2018 compensation program met these objectives and that the Company’s 2019 compensation program is appropriate in light of the challenges facing the Company and its employees.
The Committee has reviewed and discussed with management the Compensation Discussion and Analysis for 2018. Based on the review and the discussions, the Committee recommended to the Board of Directors (and the Board approved), that the Compensation Discussion and Analysis be included in Veeco’s proxy statement for its 2019 Annual Meeting of Stockholders.
This report is submitted by the Committee.
Richard A. D’Amore
Gordon Hunter (Chairman)
Thomas St. Dennis
27
The following table sets forth a summary of annual and long-term compensation awarded to, earned by, or paid for the fiscal year ended December 31, 2018 to (a) the two individuals who served as principal executive officer of Veeco during the year, (b) the principal financial officer of Veeco, and (c) the next most highly compensated executive officers (as defined in Rule 3b‑7 under the Exchange Act) of Veeco serving at the end of the year, of which there was one as of December 31, 2018 (the “NEOs”).
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
Incentive |
All |
|
|
|
|
|
Stock |
Option |
Plan |
Other |
|
Name and Principal |
|
Salary |
Bonus |
Awards |
Awards |
Compensation |
Compensation |
|
Position |
Year |
($) |
($) |
($) (1) |
($) |
($) (2) |
($) (3) |
Total ($) |
William J. Miller, Ph.D. |
2018 |
508,865 |
— |
3,041,801 |
— |
— |
17,892 |
3,568,558 |
CEO |
2017 |
470,231 |
— |
850,294 |
— |
407,048 |
17,310 |
1,744,883 |
|
2016 |
459,039 |
— |
1,401,980 |
— |
115,000 |
17,160 |
1,993,179 |
John R. Peeler |
2018 |
657,692 |
— |
999,982 |
— |
— |
53,311 |
1,710,985 |
Executive Chairman |
2017 |
700,000 |
— |
985,376 |
— |
645,208 |
72,298 |
2,402,882 |
and former CEO |
2016 |
700,000 |
— |
1,962,487 |
— |
— |
81,364 |
2,743,851 |
Shubham Maheshwari |
2018 |
463,885 |
— |
1,989,971 |
— |
— |
17,460 |
2,471,316 |
EVP, CFO and COO |
2017 |
439,500 |
— |
600,464 |
— |
304,341 |
17,310 |
1,361,615 |
|
2016 |
427,308 |
— |
999,719 |
— |
94,600 |
17,160 |
1,538,787 |
John P. Kiernan |
2018 |
307,308 |
— |
199,989 |
— |
— |
19,072 |
526,369 |
SVP, Finance, CAO |
2017 |
300,000 |
— |
200,445 |
— |
133,965 |
18,922 |
653,332 |
and Treasurer |
2016 |
300,000 |
— |
284,423 |
— |
41,250 |
17,592 |
643,265 |
(1) |
Reflects awards of restricted stock with time-based vesting and performance-based restricted stock units (“PRSUs”), which for 2018 included certain PRSUs awarded to Dr. Miller and to Mr. Maheshwari with vesting based on three-year total shareholder return. In accordance with SEC rules, the amounts shown above reflect the grant date fair value of the stock awards computed in accordance with ASC Topic 718 which, in the case of the 2018 PRSUs with vesting based on three-year total shareholder return, was determined using the Monte Carlo simulation method. Assumptions used in the calculation of these amounts are included in Note 15 to our audited financial statements for the fiscal year ended December 31, 2018. For 2018, the amounts reflected for Dr. Miller do not include a target award of 88,457 PRSUs, since that award was approved by the Compensation Committee subject to approval of an increase in the Company’s 2010 Stock Incentive Plan’s individual annual grant limit at the 2019 Annual Meeting of Stockholders. The grant date fair value of this contingent award will not be determinable until the contingency has been satisfied. For 2018, the amounts shown in the table above relate to the following stock awards: |
Restricted Stock Awards |
|||
|
Grant Date |
|
Number of |
Grant Date |
Fair Value |
Name |
Shares(a) |
03/14/2018(b) |
$19.75 |
W. Miller |
44,556 |
03/14/2018 |
|
J. Peeler |
50,632 |
03/14/2018 |
|
S. Maheshwari |
30,379 |
03/14/2018 |
|
J. Kiernan |
10,126 |
10/01/2018(c) |
$10.25 |
W. Miller |
48,780 |
10/01/2018 |
|
S. Maheshwari |
24,390 |
10/01/2018(d) |
$15.58 |
W. Miller |
106,664 |
10/01/2018 |
|
S. Maheshwari |
73,170 |
(a) |
Includes both restricted stock with time-based vesting and PRSUs, as described below. |
(b) |
Certain of the awards granted on March 14, 2018 to Dr. Miller and to Messrs. Peeler, Maheshwari and Kiernan are subject to the achievement of designated performance criteria. These PRSU awards are in the following amounts: for Dr. Miller, 22,724 shares; for Mr. Peeler, 25,822 shares; for Mr. Maheshwari, 15,493 shares; and for Mr. Kiernan, 5,164 shares. |
28
(c) |
Reflects time-based restricted stock awards made in connection with Dr. Miller’s promotion to CEO, and Mr. Maheshwari’s assumption of the additional role of COO, which will vest one quarter per year on each of the first, second, third and fourth anniversaries of the grant date. |
(d) |
Reflects PRSU awards made in connection with Dr. Miller’s promotion to CEO, and Mr. Maheshwari’s assumption of the additional role of COO, which are subject to the achievement of designated performance criteria. These awards are valued based upon the Monte Carlo simulation method. For Dr. Miller, the amounts do not include a target award of 88,457 PRSUs, since that award was approved by the Compensation Committee subject to approval of an increase in the Company’s 2010 Stock Incentive Plan’s individual annual grant limit at the 2019 Annual Meeting of Stockholders. |
(2) |
Reflects cash bonuses earned under the Company’s Management Bonus Plan. Bonuses listed for a particular year represent amounts earned with respect to such year even though all or part of such amounts may have been paid during the following year. As discussed in the Compensation Discussion and Analysis section above, the Compensation Committee determined in 2018 that no 2018 bonuses would be earned. |
(3) |
As detailed in the table below, all Other Compensation for 2018 consists of car allowances, 401(k) matching contributions, premiums for group term life insurance, and relocation\housing allowances (for which tax gross ups are not provided). |
|
|
|
Premium |
|
|
|
|
401(k) |
for Group |
Relocation |
Total |
|
Car |
Matching |
Term Life |
\ Housing |
Other |
|
Allowance |
Contribution |
Insurance |
Allowance |
Compensation |
Name |
($) |
($) |
($) |
($) |
($) |
W. Miller |
8,400 |
8,250 |
1,242 |
|
17,892 |
J. Peeler |
13,846 |
8,250 |
3,564 |
27,651(a) |
53,311 |
S. Maheshwari |
8,400 |
8,250 |
810 |
|
17,460 |
J. Kiernan |
8,400 |
8,250 |
2,322 |
|
19,072(b) |
(a) |
For Mr. Peeler, the Relocation\Housing Allowance includes amounts paid for housing, commuting and utilities. |
(b) |
For Mr. Kiernan, the amount includes a $100 Wellness Incentive payment made under the Company’s health benefit plans. |
29
The following table sets forth certain information concerning grants to each NEO during 2018 of shares of restricted stock and restricted stock units made under the Company’s 2010 Stock Incentive Plan (as amended, the “2010 Plan”). In 2018, no stock options were awarded to the NEOs. The restricted stock and restricted stock unit awards made to the NEOs in 2018 are also included in the Stock Awards column of the Summary Compensation Table.
|
|
Estimated Future Payouts |
Estimated Future Payouts |
All |
All Other |
|
|
Grant |
||||
Name |
Grant Date |
Threshold |
Target |
Maximum |
Threshold |
Target |
Maximum |
Awards: |
Option |
Exercise |
Market |
Date Fair |
W. Miller |
02/06/2018 |
117,288 |
533,125 |
1,066,250 |
|
|
|
|
|
|
|
|
|
03/14/2018 |
|
|
|
8,522 |
22,724 |
34,086 |
21,832 |
|
|
|
879,981 |
|
10/01/2018 |
|
|
|
53,332 |
106,664 |
213,328 |
48,780 |
|
|
|
2,161,820 |
J. Peeler |
02/06/2018 |
160,325 |
728,750 |
1,457,500 |
|
|
|
|
|
|
|
|
|
03/14/2018 |
|
|
|
9,684 |
25,822 |
38,733 |
24,810 |
|
|
|
999,982 |
S. Maheshwari |
02/06/2018 |
85,470 |
388,500 |
777,000 |
|
|
|
|
|
|
|
|
|
03/14/2018 |
|
|
|
5,810 |
15,493 |
23,240 |
14,886 |
|
|
|
599,985 |
|
10/01/2018 |
|
|
|
36,585 |
73,170 |
146,340 |
24,390 |
|
|
|
1,389,986 |
J. Kiernan |
02/06/2018 |
34,100 |
155,000 |
310,000 |
|
|
|
|
|
|
|
|
|
03/14/2018 |
|
|
|
1,937 |
5,164 |
7,746 |
4,962 |
|
|
|
199,989 |
(1) |
Reflects the annual cash incentive opportunities approved by the Compensation Committee in the first quarter of 2018. As further discussed in the Compensation Discussion and Analysis above, at the recommendation of Company management, the Compensation Committee exercised its discretion in the third quarter of 2018 to cancel the incentive opportunities and no annual incentives were earned in 2018. |
(2) |
The equity incentive plan awards consist of PRSUs granted March 14, 2018, with vesting based one-half on cumulative revenue and one-half on EBITDA (the “Annual Awards”), and PRSUs granted to Dr. Miller and Mr. Maheshwari on October 1, 2018, with vesting based on total shareholder return (the “TSR Awards”). Each of the awards has a three-year performance period. If threshold performance is achieved (i) the portion of the Annual Awards based on revenue is earned at 25% of target and the portion based on EBITDA is earned at 50% of target and (ii) the TSR Awards are earned at 50% of target. If maximum performance is achieved, the Annual Awards are earned at 150% of target and the TSR Awards are earned at 200% of target. Performance outcomes will be determined following the conclusion of the respective performance period. Each of the awards is subject to 100% forfeiture if threshold performance is not achieved. The TSR Award reflected in the table for Dr. Miller does not include a target award of 88,457 PRSUs, since that award was approved by the Compensation Committee subject to stockholders’ approval of an increase in the 2010 Plan’s individual annual grant limit at the 2019 Annual Meeting of Stockholders. |
(3) |
Reflects time-based restricted stock awards that vest over four years. |
Outstanding Equity Awards at Fiscal Year End
The following table provides certain information as of December 31, 2018 concerning unexercised options and stock awards that had been granted but had not yet vested as of such date for each of the NEOs. The
30
value of stock awards shown below is based upon the fair market value of the Company’s common stock on December 31, 2018, which was $7.41 per share.
|
Option Awards |
Stock Awards |
||||||
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
Equity |
Incentive |
|
|
|
|
|
|
|
Incentive |
Plan Awards: |
|
|
|
|
|
|
|
Plan Awards: |
Market or |
|
|
|
|
|
|
Market |
Number of |
Payout Value |
|
|
|
|
|
Number of |
Value of |
Unearned |
of Unearned |
|
Number of |
Number of |
|
|
Shares or |
Shares or |
Shares, Units |
Shares, Units |
|
Securities |
Securities |
|
|
Units of |
Units of |
or Other |
or Other |
|
Underlying |
Underlying |
|
|
Stock That |
Stock That |
Rights That |
Rights That |
|
Unexercised |
Unexercised |
Option |
|
Have Not |
Have Not |
Have Not |
Have Not |
|
Options (#) |
Options (#) |
Exercise |
Option |
Vested |
Vested |
Vested |
Vested |
Name |
Exercisable |
Unexercisable |
Price ($) |
Expiration Date |
(#) (1) |
($) |
(#) (1) |
($) |
W. Miller |
41,000 |
|
34.13 |
06/10/2020 |
110,034 |
815,352 |
188,722 |
1,398,430 |
|
12,900 |
|
51.70 |
06/08/2021 |
|
|
|
|
|
35,000 |
|
33.00 |
05/24/2022 |
|
|
|
|
|
16,000 |
|
30.47 |
12/12/2023 |
|
|
|
|
|
12,410 |
|
32.67 |
06/11/2021 |
|
|
|
|
J. Peeler |
84,400 |
|
34.13 |
06/10/2020 |
63,396 |
469,764 |
125,414 |
929,318 |
|
31,700 |
|
51.70 |
06/08/2021 |
|
|
|
|
|
80,000 |
|
33.00 |
05/24/2022 |
|
|
|
|
|
60,330 |
|
30.47 |
12/12/2023 |
|
|
|
|
|
26,180 |
|
32.67 |
06/11/2021 |
|
|
|
|
S. Maheshwari |
54,000 |
|
33.32 |
06/01/2024 |
62,006 |
459,464 |
134,707 |
998,179 |
J. Kiernan |
11,734 |
|
34.13 |
06/10/2020 |
11,698 |
86,682 |
20,709 |
153,454 |
|
7,000 |
|
51.70 |
06/08/2021 |
|
|
|
|
|
18,500 |
|
33.00 |
05/24/2022 |
|
|
|
|
|
8,000 |
|
30.47 |
12/12/2023 |
|
|
|
|
|
4,620 |
|
32.67 |
06/11/2021 |
|
|
|
|
(1) |
Reflects awards of restricted stock with time-based vesting and PRSUs which were not vested as of December 31, 2018. These awards are scheduled to vest as follows (PRSU amounts assume target achievement): |
(a) |
Awards made on June 12, 2014 to Dr. Miller and to Messrs. Peeler and Kiernan included PRSU awards which were made subject to the achievement of designated performance criteria. As of December 31, 2018, certain of the PRSU awards remained unvested (and subject to the achievement of designated performance criteria), specifically in the following amounts: for Dr. Miller, 5,755 shares; for Mr. Peeler, 12,149 shares; and for Mr. Kiernan, 2,145 shares. In February 2019 it was determined that certain of the performance criteria for these awards had been achieved, resulting in a portion of the awards vesting and the remaining portion of the awards being forfeited at that time. |
(b) |
Awards made on June 12, 2015 to all NEOs included restricted stock awards that are scheduled to vest one third per year on each of the second, third and fourth anniversaries of the grant date, specifically as follows: for Dr. Miller, 12,350 shares; for Mr. Peeler, 15,640 shares; for Mr. Maheshwari, 11,550 shares; and for Mr. Kiernan, 3,270 shares. The remaining shares were granted in the form of PRSU awards. As of December 31, 2018, the unvested PRSU award amounts were as follows: for Dr. Miller, 12,850 shares; for Mr. Peeler, 26,620 shares; for Mr. Maheshwari, 12,020 shares; and for Mr. Kiernan, 3,400 shares. |
(c) |
A restricted stock award made to Dr. Miller on January 4, 2016 fully vested on January 4, 2019, the third anniversary of the grant date. |
(d) |
Awards made on June 14, 2016 to all NEOs included restricted stock awards that are scheduled to vest one quarter per year on each of the first, second, third and fourth anniversaries of the grant date, specifically as follows: for Dr. Miller, 21,420 shares; for Mr. Peeler, 35,930 shares; for Mr. Maheshwari, 20,040 shares; and for Mr. Kiernan, 6,220 shares. The remaining shares were granted in the form of PRSU awards. As of December 31, 2018, the unvested PRSU award amounts were as follows: for Dr. Miller, 22,300 shares; for Mr. Peeler, 37,400 shares; for Mr. Maheshwari, 20,860 shares; and for Mr. Kiernan, 6,480 shares. |
(e) |
Awards made on December 14, 2016 to Dr. Miller and to Messrs. Peeler and Maheshwari included restricted stock awards that are scheduled to vest one quarter per year on each of the first, second, third and fourth anniversaries of the grant date, specifically as follows: for Dr. Miller, 3,362 shares; for Mr. Peeler, 5,883 shares; and for Mr. Maheshwari, 2,521 shares. The remaining shares were granted in the form of PRSU awards. As of December 31, 2018, the unvested PRSU award amounts were as follows: for Dr. Miller, 3,499 shares; for Mr. Peeler, 6,123 shares; and for Mr. Maheshwari, 2,624 shares. |
31
(f) |
Awards made on June 16, 2017 to all NEOs included restricted stock awards that are scheduled to vest one quarter per year on each of the first, second, third and fourth anniversaries of the grant date, specifically as follows: for Dr. Miller, 14,340 shares; for Mr. Peeler, 16,620 shares; for Mr. Maheshwari, 10,130 shares; and for Mr. Kiernan, 3,380 shares. The remaining shares were granted in the form of PRSU awards. As of December 31, 2018, the unvested PRSU award amounts were as follows: for Dr. Miller, 14,930 shares; for Mr. Peeler, 17,300 shares; for Mr. Maheshwari, 10,540 shares; and for Mr. Kiernan, 3,520 shares. |
(g) |
Awards made on March 14, 2018 to all NEOs included restricted stock awards that are scheduled to vest in twenty percent (20%) increments at specified times over a four-year period following the grant date, specifically in the following amounts: for Dr. Miller, 21,832 shares; for Mr. Peeler, 24,810 shares; for Mr. Maheshwari, 14,886 shares; and for Mr. Kiernan, 4,962 shares. The remaining shares were granted in the form of PRSU awards. As of December 31, 2018, the unvested PRSU award amounts were as follows: for Dr. Miller, 22,724 shares; for Mr. Peeler, 25,822 shares; for Mr. Maheshwari, 15,493 shares; and for Mr. Kiernan, 5,164 shares. |
(h) |
Awards made on October 1, 2018 to Dr. Miller and to Mr. Maheshwari included restricted stock awards that are scheduled to vest one quarter per year on each of the first, second, third and fourth anniversaries of the grant date, specifically as follows: for Dr. Miller, 48,780 shares, and for Mr. Maheshwari, 24,390 shares. The remaining shares were granted in the form of PRSU awards. As of December 31, 2018, the unvested PRSU award amounts were as follows: for Dr. Miller, 106,664 shares; and for Mr. Maheshwari, 73,170 shares. The unvested PRSU award amount for Dr. Miller does not include a target award of 88,457 PRSUs, since that award was approved by the Compensation Committee subject to approval of an increase in the Company’s 2010 Stock Incentive Plan’s individual annual grant limit at the 2019 Annual Meeting of Stockholders. |
32
In all cases, except as otherwise specified, vesting of stock options and restricted stock is subject to the recipient’s continued employment. The grant dates for the awards shown above which were not vested as of December 31, 2018 are as follows:
|
Option Awards |
Stock Awards |
|||
Name |
Number of |
Option |
Option |
Number of |
Restricted |
W. Miller |
|
|
|
5,755 |
06/12/2014 |
|
|
|
|
16,967 |
06/12/2015 |
|
|
|
|
12,159 |
01/04/2016 |
|
|
|
|
33,010 |
06/14/2016 |
|
|
|
|
5,180 |
12/14/2016 |
|
|
|
|
25,685 |
06/16/2017 |
|
|
|
|
44,556 |
03/14/2018 |
|
|
|
|
155,444 |
10/01/2018 |
J. Peeler |
|
|
|
12,149 |
06/12/2014 |
|
|
|
|
31,834 |
06/12/2015 |
|
|
|
|
55,365 |
06/14/2016 |
|
|
|
|
9,065 |
12/14/2016 |
|
|
|
|
29,765 |
06/16/2017 |
|
|
|
|
50,632 |
03/14/2018 |
S. Maheshwari |
|
|
|
15,871 |
06/12/2015 |
|
|
|
|
30,880 |
06/14/2016 |
|
|
|
|
3,885 |
12/14/2016 |
|
|
|
|
18,138 |
06/16/2017 |
|
|
|
|
30,379 |
03/14/2018 |
|
|
|
|
97,560 |
10/01/2018 |
J. Kiernan |
|
|
|
2,145 |
06/12/2014 |
|
|
|
|
4,491 |
06/12/2015 |
|
|
|
|
9,590 |
06/14/2016 |
|
|
|
|
6,055 |
06/16/2017 |
|
|
|
|
10,126 |
03/14/2018 |
(1) |
Includes awards of both restricted stock with time-based vesting and PRSUs. |
Options Exercises and Stock Vested During 2018
The following table sets forth certain information concerning the exercise of stock options and the vesting of shares of restricted stock during the last fiscal year for each of the NEOs.
|
Option Awards |
Stock Awards |
||
|
Number of |
|
Number of |
|
|
Shares |
|
Shares |
|
|
|